127 related articles for article (PubMed ID: 7693296)
1. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres.
Williams G; Coulange C; Milroy EJ; Sarramon JP; Rubben H
Br J Urol; 1993 Sep; 72(3):335-40. PubMed ID: 7693296
[TBL] [Abstract][Full Text] [Related]
2. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
3. Experience with the second generation UroLume prostatic stent.
Bajoria S; Agarwal SA; White R; Zafar F; Williams G
Br J Urol; 1995 Mar; 75(3):325-7. PubMed ID: 7735798
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
5. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate.
Pétas A; Talja M; Tammela TL; Taari K; Välimaa T; Törmälä P
Br J Urol; 1997 Sep; 80(3):439-43. PubMed ID: 9313664
[TBL] [Abstract][Full Text] [Related]
6. Experience with the Memotherm permanently implanted prostatic stent.
Williams G; White R
Br J Urol; 1995 Sep; 76(3):337-40. PubMed ID: 7551842
[TBL] [Abstract][Full Text] [Related]
7. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.
McLoughlin J; Jager R; Abel PD; el Din A; Adam A; Williams G
Br J Urol; 1990 Jul; 66(1):66-70. PubMed ID: 1697492
[TBL] [Abstract][Full Text] [Related]
8. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
[TBL] [Abstract][Full Text] [Related]
9. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?
Sethi K; Bozin M; Jabane T; McMullin R; Cook D; Forsyth R; Dodds L; Putra LJ
Investig Clin Urol; 2017 Nov; 58(6):447-452. PubMed ID: 29124245
[TBL] [Abstract][Full Text] [Related]
10. The use of intraurethral prostatic spiral in high risk patients for surgery with benign prostatic hyperplasia.
Ozgür GK; Sivrikaya A; Bilen R; Biberoğlu K; Gümele HR
Int Urol Nephrol; 1993; 25(1):65-70. PubMed ID: 7685746
[TBL] [Abstract][Full Text] [Related]
11. [Long-term temporary prosthesis in prostatic obstruction. ProstaCoil, an expanding, self-fixating implant of large caliber].
Yachia D
J Urol (Paris); 1993; 99(6):328-31. PubMed ID: 7516381
[TBL] [Abstract][Full Text] [Related]
12. Intraurethral catheter in high-risk patients with urinary retention: 3 years of experience.
Sassine AM; Schulman CC
Eur Urol; 1994; 25(2):131-4. PubMed ID: 7511105
[TBL] [Abstract][Full Text] [Related]
13. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a tubular mesh and a spiral stent woven from titanium nickel alloy for prostatic obstruction in patients at high risk for surgery. Report of 62 cases.
Sun Y; Wang J; Li J; Zhang Y; Yao Y
Chin Med J (Engl); 1995 Oct; 108(10):769-73. PubMed ID: 8565664
[TBL] [Abstract][Full Text] [Related]
15. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
16. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
Laaksovirta S; Isotalo T; Talja M; Välimaa T; Törmälä P; Tammela TL
J Endourol; 2002 Jun; 16(5):311-5. PubMed ID: 12184083
[TBL] [Abstract][Full Text] [Related]
17. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
[TBL] [Abstract][Full Text] [Related]
18. Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report.
Chapple CR; Milroy EJ; Rickards D
Br J Urol; 1990 Jul; 66(1):58-65. PubMed ID: 1697491
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
[TBL] [Abstract][Full Text] [Related]
20. The titanium intraprostatic stent: the United States experience.
Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
